NCT03091257 2026-03-13A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaMassachusetts General HospitalPhase 1 Active not recruiting30 enrolled
NCT01947023 2025-11-05Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1 Active not recruiting21 enrolled